Emerson Padiernos

669 total citations
8 papers, 122 citations indexed

About

Emerson Padiernos is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Molecular Biology. According to data from OpenAlex, Emerson Padiernos has authored 8 papers receiving a total of 122 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Pulmonary and Respiratory Medicine, 4 papers in Oncology and 2 papers in Molecular Biology. Recurrent topics in Emerson Padiernos's work include Occupational and environmental lung diseases (4 papers), Cancer-related Molecular Pathways (2 papers) and Cell death mechanisms and regulation (2 papers). Emerson Padiernos is often cited by papers focused on Occupational and environmental lung diseases (4 papers), Cancer-related Molecular Pathways (2 papers) and Cell death mechanisms and regulation (2 papers). Emerson Padiernos collaborates with scholars based in United States and India. Emerson Padiernos's co-authors include Charles D. Lopez, Izidore S. Lossos, Louie Naumovski, William H. Fleming, Dexi Chen, Christopher L. Corless, Dean W. Felsher, Kerstin Maria Kampa-Schittenhelm, Alexis S. Bailey and Alice C. Fan and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Oncology and The Lancet Oncology.

In The Last Decade

Emerson Padiernos

8 papers receiving 121 citations

Peers

Emerson Padiernos

MB

ONCOL

PRM

CB

CR

Ramona Crescenzo United States

Jianong Zhang China

Natasha Morse United States

Lisa Elefanti Italy

Pierre Foidart Belgium

Isabelle Csete United States

Sheng Yu United Kingdom

Xuemei Zuo United States

Sven Beyes Germany

Yuanfang Zhai China

Ramona Crescenzo United States

Emerson Padiernos

80 ×1.0

MB

52 ×0.8

ONCOL

23 ×0.9

PRM

12 ×0.6

CB

10 ×0.6

CR

Citations per year, relative to Emerson Padiernos Emerson Padiernos (= 1×) peers Ramona Crescenzo

Countries citing papers authored by Emerson Padiernos

Since Specialization

Citations

This map shows the geographic impact of Emerson Padiernos's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Emerson Padiernos with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Emerson Padiernos more than expected).

Fields of papers citing papers by Emerson Padiernos

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Emerson Padiernos. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Emerson Padiernos. The network helps show where Emerson Padiernos may publish in the future.

Co-authorship network of co-authors of Emerson Padiernos

This figure shows the co-authorship network connecting the top 25 collaborators of Emerson Padiernos. A scholar is included among the top collaborators of Emerson Padiernos based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Emerson Padiernos. Emerson Padiernos is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

8 of 8 papers shown

1.

Mian, Idrees, Emerson Padiernos, Raffit Hassan, & Azam Ghafoor. (2020). Orbital metastases from malignant mesothelioma. The Lancet Oncology. 21(2). e117–e117. 1 indexed citations

2.

Reynolds, James C., Roberto Maass‐Moreno, Anish Thomas, et al.. (2020). ¹⁸F-FDG PET Assessment of Malignant Pleural Mesothelioma: Total Lesion Volume and Total Lesion Glycolysis—The Central Role of Volume. Journal of Nuclear Medicine. 61(11). 1570–1575. 4 indexed citations

3.

Hassan, Raffit, Idrees Mian, Emerson Padiernos, et al.. (2020). Phase II study of olaparib in malignant mesothelioma (MM) to correlate efficacy with germline and somatic mutations in DNA repair genes.. Journal of Clinical Oncology. 38(15_suppl). 9054–9054. 12 indexed citations

4.

Kim, Chul, Nitin Roper, Chuong D. Hoang, et al.. (2018). Local ablative therapy (LAT) for oligoprogressive, EGFR-mutant, non-small cell lung cancer (NSCLC) after treatment with osimertinib.. Journal of Clinical Oncology. 36(15_suppl). e21080–e21080. 5 indexed citations

5.

Hassan, Raffit, Betsy Morrow, Tom Walsh, et al.. (2018). Inherited predisposition to malignant mesothelioma (MM) due to mutations in DNA repair genes.. Journal of Clinical Oncology. 36(15_suppl). 8504–8504. 4 indexed citations

6.

Kim, Chul, Nitin Roper, Chuong D. Hoang, et al.. (2017). Local ablative therapy (LAT) for oligoprogressive, EGFR-mutant, non-small cell lung cancer (NSCLC) after treatment with osimertinib.. Journal of Clinical Oncology. 35(15_suppl). e20545–e20545. 2 indexed citations

7.

Kampa-Schittenhelm, Kerstin Maria, Jared D. Acoba, Dexi Chen, et al.. (2009). Apoptosis-stimulating protein of p53 (ASPP2) heterozygous mice are tumor-prone and have attenuated cellular damage–response thresholds. Proceedings of the National Academy of Sciences. 106(11). 4390–4395. 42 indexed citations

8.

Padiernos, Emerson, et al.. (2004). Apoptosis-stimulating protein of p53-2 (ASPP2/53BP2L) is an E2F target gene. Cell Death and Differentiation. 12(4). 358–368. 52 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact